Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Ustekinumab induces responses in patients with Crohn's disease

May 16, 2011

Chemokine CCR8 receptor antagonist R-243 may prevent peritoneal adhesion

May 16, 2011

Clinical study determines pharmacokinetics of oral formulation of antibiotic TP-434

May 16, 2011

First-in-class antimicrobial zempia is active against clinical bacterial isolates

May 16, 2011

New antiviral agent OBR-5-340 is active against coxsackievirus B3 and rhinovirus 5

May 13, 2011

First-in-human data reported on FAB Pharma's antibacterial agent MUT-056399

May 13, 2011

Snapshots: Promising preclinical data on ImmunoGen's anticancer agents IMGN-853 and IMGN-529

May 13, 2011

KAG-308 has beneficial effects in models of chronic colitis

May 12, 2011

Preclinical data disclosed on RDX-5791 for constipation

May 12, 2011

PEM antibiotic POL-7080 well tolerated in phase I study

May 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...